Date published: 2025-9-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

TP53TG5 Activators

TP53TG5, also known as TP53 Target 5, is a non-coding RNA gene that is part of the p53 signaling pathway. TP53, the protein encoded by the TP53 gene, is a well-known tumor suppressor and transcription factor that plays a critical role in regulating the cell cycle, apoptosis, and genomic stability. It is activated in response to various cellular stresses, including DNA damage, oncogene activation, and hypoxia.Non-coding RNAs, such as TP53TG5, are RNA molecules that are not translated into proteins but have regulatory functions in the cell. TP53TG5 is thought to be involved in the p53-dependent stress response. As a transcriptional target of TP53, it may have a role in modulating the expression of other genes that are part of the p53 network, contributing to the tumor suppressor functions of p53.

The specific mechanisms by which TP53TG5 functions are not fully understood, but it is believed to interact with other molecular components to influence cell fate decisions. Research suggests that TP53TG5 could be involved in the regulation of apoptosis, cellular senescence, or DNA repair processes, which are all pivotal in preventing the development of cancer.The expression of TP53TG5 can serve as a biomarker for p53 activity within cells, providing a potential tool for studying the status of the p53 pathway in various contexts, including cancer research. As non-coding RNAs continue to be an area of intense study, the functions of TP53TG5 and its impact on the p53 pathway are subjects of interest that may reveal new insights into the complex network of gene regulation controlled by p53. Understanding the role of TP53TG5 could contribute to the development of novel strategies for cancer diagnosis and therapy, particularly in cancers where the p53 pathway is disrupted.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Nutlin-3

548472-68-0sc-45061
sc-45061A
sc-45061B
1 mg
5 mg
25 mg
$56.00
$212.00
$764.00
24
(1)

MDM2 antagonist, stabilizes p53 by preventing its degradation, potentially affecting TP53TG5 through p53-mediated pathways.

Doxorubicin

23214-92-8sc-280681
sc-280681A
1 mg
5 mg
$173.00
$418.00
43
(3)

Chemotherapeutic agent that induces DNA damage, potentially influencing TP53TG5 expression through p53 activation in response to DNA damage.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$57.00
$182.00
$92.00
21
(2)

Topoisomerase I inhibitor, induces DNA damage, potentially influencing TP53TG5 by activating p53-dependent pathways.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$32.00
$170.00
$385.00
63
(1)

Topoisomerase II inhibitor, can induce DNA damage and potentially influence TP53TG5 through p53-mediated mechanisms.

Fluorouracil

51-21-8sc-29060
sc-29060A
1 g
5 g
$36.00
$149.00
11
(1)

Antimetabolite chemotherapeutic, can induce p53-mediated cellular responses, potentially influencing TP53TG5 expression.

Cisplatin

15663-27-1sc-200896
sc-200896A
100 mg
500 mg
$76.00
$216.00
101
(4)

Chemotherapeutic agent causing DNA crosslinking, potentially affecting TP53TG5 through p53 activation due to DNA damage.

Veliparib

912444-00-9sc-394457A
sc-394457
sc-394457B
5 mg
10 mg
50 mg
$178.00
$270.00
$712.00
3
(0)

PARP inhibitor, enhances DNA damage effects in cancer cells, potentially influencing TP53TG5 via p53 activation pathways.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$206.00
$299.00
$485.00
10
(1)

PARP inhibitor, used in cancer therapy, may affect TP53TG5 by enhancing p53-mediated responses to DNA damage.

Palbociclib

571190-30-2sc-507366
50 mg
$315.00
(0)

CDK4/6 inhibitor, can cause cell cycle arrest and potentially influence TP53TG5 expression through p53-regulated pathways.

ABT 263

923564-51-6sc-207241
5 mg
$240.00
16
(1)

Bcl-2 family protein inhibitor, can induce apoptosis, potentially affecting TP53TG5 in a p53-dependent manner.